Home

Gore has announced the first US implant of its Gore TAG conformable thoracic stent graft with ACTIVE CONTROL system. The successful procedure was performed by William Jordan, chief of the Division of Vascular Surgery and Bradley Leshnower, cardiothoracic surgeon, at the Emory University School of Medicine in Atlanta, USA. This first case follows the recent US Food and Drug Administration approval for this new device.

The system delivers new levels of control in the endovascular repair of aneurysms, transections, and Type B dissections of the thoracic aorta. A key feature of this device is a delivery system which provides controlled, two-stage deployment, with primary deployment to an intermediate diameter and a secondary deployment to full diameter. In addition to the staged deployment, a lockwire keeps the stent graft attached to the catheter through the procedure, enhancing the physician’s control. The device also features a full 2F reduction in profile over previous designs across 10 device sizes.

“The two-stage deployment provided by the Gore TAG conformable thoracic stent graft with ACTIVE CONTROL system allows for continuous blood flow, and it gives me multiple opportunities to visualise and refine graft placement for accurate placement and peace of mind,” said Jordan. “The new delivery system gives me added precision in placement and angulation so I can take full advantage of the conformability of the Gore device and confidently provide a minimally-invasive solution to more patients, even in patients with complex anatomy.”

The system received CE Mark in 2017. At 30-day follow-up, the device demonstrated 100% successful deployment and zero type IA or type III endoleaks, fractures, device compressions or ruptures, according to real-world data from the post-market European observational, single-arm SURPASS registry. No device-related issues were reported by 98.4% of registry participants, and 97.2% of registry subjects were reported free from serious access complications. Further, 98.4% of registry participants reported improved proximal wall apposition at procedural completion, and 92.9% reported no rapid pacing was used.

“Gore has continuously partnered with physicians to innovate and evolve our stent graft offerings to deliver better long-term patient care,” said Eric Zacharias, vascular business leader at Gore. “We engineered this device with the goal of overcoming known thoracic endovascular aortic repair (TEVAR) limitations related to control and accuracy during deployment. With this new milestone, Gore continues its commitment to developing solutions that advance the treatment of endovascular aortic disease.”

Source VascularNews

Duc Tin Clinic

Chia sẽ qua facebook bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua google bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua twitter bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua MySpace bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua LinkedIn bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua stumbleupon bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua icio bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua digg bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Chia sẽ qua yahoo bài: First US patient receives Gore TAG conformable thoracic stent graft with ACTIVE CONTROL

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.